一般演題（口演）18 免疫チェックポイント阻害剤（臨床試験）

[O18-4] 演題取消し

^○Ryo Ariyasu¹, Luis Paz-Ares², Federico Cappuzzo³, Noboru Yamamoto⁴, Natalie Vokes⁵, Jhanelle E. Gray⁶, Taofeek Owonikoko⁷, Hidenobu Ishii⁸, Jin Hyoung Kang⁹, Se-Hoon Lee¹⁰, Roland Hallwachs¹¹, Anna Coenen-Stass¹¹, Barbara Sarholz¹¹, Linda Pudelko¹¹, Jatinder Kaur Mukker¹², Camilo Moulin¹³, Ioannis Gounaris¹⁴, Liza C. Villaruz¹⁵ (1.Cancer Institute Hospital of JFCR, Tokyo, Japan, 2.Hospital Universitario 12 de Octubre, Madrid, Spain, 3.Azienda Unità Sanitaria Locale, AUSL della Romagna, Ravenna, Italy, 4.National Cancer Center Hospital, Tokyo, Japan, 5.The University of Texas, MD Anderson Cancer Center, Houston, USA, 6.Moffitt Cancer Center, Tampa, USA, 7.University of Pittsburgh, Pittsburgh, USA, 8.Kurume University Hospital, Kurume, Japan, 9.Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, 10.Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 11.Merck Healthcare KGaA, Darmstadt, Germany, 12.EMD Serono Research ＆ Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA, 13.Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, 14.Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA, 15.UPMC Hillman Cancer Center, Pittsburgh, PA, USA)

アンコール演題